Cover Image

Pharmacogene Variation in Thai Plasmodium vivax Relapse Patients Treated with a Combination of Primaquine and Chloroquine

Monpat Chamnanphon, 1 Andrea Gaedigk, 2 Apichaya Puangpetch, 3, 4 Ekawat Pasomsub, 5 Wasun Chantratita, 6 Rhea J Longley, 7, 8 Jetsumon Sattabongkot, 7 Pajaree Chariyavilaskul, 1 Chonlaphat Sukasem 3, 4 1Clinical Pharmacokinetics and Pharmacogenomics Research Unit, Department of Pharmacology, Facult...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chamnanphon M (Author), Gaedigk A (Author), Puangpetch A (Author), Pasomsub E (Author), Chantratita W (Author), Longley RJ (Author), Sattabongkot J (Author), Chariyavilaskul P (Author), Sukasem C (Author)
Format:	Book
Published:	Dove Medical Press, 2020-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of Sensitivity of Plasmodium vivax to Chloroquine
by: Nateghpour M, et al.
Published: (2007)

Evaluation of Sensitivity of Plasmodium vivax to Chloroquine
by: Nateghpour M, et al.
Published: (2007)

Chloroquine-resistant Plasmodium vivax in Pakistan: an emerging threat
by: Ammara Khan, et al.
Published: (2016)

Dual Loading Of Primaquine And Chloroquine Into Liposome
by: Miatmoko A., et al.
Published: (2019)

Effects of liver-stage clearance by Primaquine on gametocyte carriage of Plasmodium vivax and P. falciparum.
by: Rahel Wampfler, et al.
Published: (2017)

Influence of SULT1A1&ast;2 Polymorphism on Plasma Efavirenz Concentration in Thai HIV-1 Patients
by: Chamnanphon M, et al.
Published: (2021)

Hypnozoite depletion in successive Plasmodium vivax relapses.
by: Rintis Noviyanti, et al.
Published: (2022)

Population heterogeneity in Plasmodium vivax relapse risk.
by: Eva Stadler, et al.
Published: (2022)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
by: Walter R J Taylor, et al.
Published: (2023)

Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil.
by: Rodrigo M Corder, et al.
Published: (2020)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
by: Kamala Thriemer, et al.
Published: (2020)

Global perspectives on CYP2D6 associations with primaquine metabolism and Plasmodium vivax radical cure
by: Jasmine M. Olvany, et al.
Published: (2022)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
by: Walter R J Taylor, et al.
Published: (2021)

Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
by: Alexandra G. A. Stewart, et al.
Published: (2021)

Recurrencias de malaria por Plasmodium vivax según el uso de primaquina: análisis de estudios descriptivos longitudinales Plasmodium vivax malaria recurrence according to the use of primaquine: analysis of longitudinal descriptive studies
by: Jaime Carmona-Fonseca
Published: (2012)

Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen
by: Chamnanphon M, et al.
Published: (2013)

G6PD deficiency at Sumba in Eastern Indonesia is prevalent, diverse and severe: implications for primaquine therapy against relapsing Vivax malaria.
by: Ari Winasti Satyagraha, et al.
Published: (2015)

Linked-evidence modelling of qualitative G6PD testing to inform low- and intermediate-dose primaquine treatment for radical cure of Plasmodium vivax.
by: Michelle L Gatton
Published: (2024)

Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts.
by: Jason Rosado, et al.
Published: (2021)

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
by: Ebstie YA, et al.
Published: (2016)

CYP2D6 Predicts Plasma Donepezil Concentrations in a Cohort of Thai Patients with Mild to Moderate Dementia
by: Chamnanphon M, et al.
Published: (2020)

Using G6PD tests to enable the safe treatment of Plasmodium vivax infections with primaquine on the Thailand-Myanmar border: A cost-effectiveness analysis.
by: Angela Devine, et al.
Published: (2017)

Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
by: James Watson, et al.
Published: (2018)

Substantial population structure of Plasmodium vivax in Thailand facilitates identification of the sources of residual transmission.
by: Veerayuth Kittichai, et al.
Published: (2017)

Pharmacogenomics Factors Influencing the Effect of Risperidone on Prolactin Levels in Thai Pediatric Patients With Autism Spectrum Disorder
by: Yaowaluck Hongkaew, et al.
Published: (2021)

Pharmacogenomic study reveals new variants of drug metabolizing enzyme and transporter genes associated with steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in Thai autism spectrum disorder patients
by: Sadeep Medhasi, et al.
Published: (2016)

Plasmodium vivax Transmission in Africa.
by: Rosalind E Howes, et al.
Published: (2015)

CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors
by: Sukasem C, et al.
Published: (2013)

Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions.
by: Rhea J Longley, et al.
Published: (2017)

Identification of the asymptomatic Plasmodium falciparum and Plasmodium vivax gametocyte reservoir under different transmission intensities.
by: Cristian Koepfli, et al.
Published: (2021)

Supervised administration of primaquine may enhance adherence to radical cure for P. vivax malaria in India
by: Manju Rahi, et al.
Published: (2023)

Neutrophil paralysis in Plasmodium vivax malaria.
by: Fabiana Maria de Souza Leoratti, et al.
Published: (2012)

Plasmodium vivax malaria: Is it actually benign?
by: Harpal Singh, et al.
Published: (2011)

The Incidence and Differential Seasonal Patterns of Plasmodium vivax Primary Infections and Relapses in a Cohort of Children in Papua New Guinea.
by: Amanda Ross, et al.
Published: (2016)

Plasmodium Falciparum Versus Plasmodium Vivax: Which Is a Lesser Evil?
by: Chirag C Rathod, et al.
Published: (2012)

Economic Evaluation of Multiple-Pharmacogenes Testing for the Prevention of Adverse Drug Reactions in People Living with HIV
by: Turongkaravee S, et al.
Published: (2022)

In-house validation of a lamp kit for diagnosis of Plasmodium, Plasmodium falciparum and Plasmodium vivax in Vietnam
by: Nguyen Thi Hong Ngoc, et al.
Published: (2020)

Gametocitos de Plasmodium vivax y Plasmodium falciparum: etapas relegadas en el desarrollo de vacunas Plasmodium vivax and Plasmodium falciparum gametocyte stages are neglected in vaccine development
by: Carla Contreras-Ochoa, et al.
Published: (2004)

The Plasmodium vivax merozoite surface protein 3β sequence reveals contrasting parasite populations in southern and northwestern Thailand.
by: Chaturong Putaporntip, et al.
Published: (2014)

Rheopathologic Consequence of Plasmodium vivax Rosette Formation.
by: Rou Zhang, et al.
Published: (2016)